CCCC   $6.36  -3.49% Market Closed After Close 6.35 -0.16%

C4 Therapeutics Inc
Total Cash 264.10M
totalCashPerShare 3.809
EBITDA -114.69M
Total Debt 68.42M
quickRatio 4.894
currentRatio 5.093
Total Revenue 29.38M
debtToEquity 27.693
Revenue/Share 0.494
ROA -0.19253
ROE -0.44873002
grossProfits
freeCashflow -33.95M
operatingCashflow -77.81M
earningsGrowth
revenueGrowth 3.507
grossMargins -2.57492
ebitdaMargins 0.0
operatingMargins -1.7859399
profitMargins 0.0
enterpriseValue 250.85M
forwardPE -3.8041463
floatShares 45.79M
sharesOutstanding 69.34M
sharesShort 11.63M
sharesShortPriorMonth 10.47M
dateShortInterest
sharesPercentSharesOut 0.17%
heldPercentInsiders 0.12%
heldPercentInstitutions 0.88%
Short Ratio help_outline 12.18%
shortPercentOfFloat 0.20%
impliedSharesOutstanding
bookValue 3.59
Price To Book help_outline 1.74
earningsQuarterlyGrowth
netIncomeToCommon -107.87M
trailingEps -1.90%
forwardEps -1.64%
enterpriseToEbitda -2.19
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.38 3Q 2024
institutionsCount 149
lastUpdated Sept. 16, 2024, 8:03 p.m.